Cognition and Psychotherapy in PTSD
1 other identifier
observational
110
1 country
1
Brief Summary
Posttraumatic stress disorder (PTSD) is prevalent among combat Veterans and is a substantial public health burden. Several psychotherapies, including cognitive processing therapy (CPT) and prolonged exposure therapy, have been recommended as efficacious for the treatment of PTSD and are being disseminated nationally in the VA Healthcare System. Yet many individuals show limited benefit from such treatments. Accumulating evidence indicates that episodic memory deficits may be one factor limiting psychotherapy treatment efficacy in PTSD. The proposed study will determine whether verbal memory is a specific predictor of CPT outcomes in PTSD, including both symptom reductions and functional outcomes. The study will also determine the pathways by which memory functioning affects treatment outcomes by examining relationships between memory functioning, treatment engagement, recall of treatment content, and illness course. More specifically, analyses will examine whether memory for treatment content affects the relationship between memory functioning and treatment outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2018
CompletedFirst Posted
Study publicly available on registry
August 22, 2018
CompletedStudy Start
First participant enrolled
May 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2023
CompletedResults Posted
Study results publicly available
May 9, 2025
CompletedMay 9, 2025
May 1, 2025
4.4 years
August 20, 2018
December 26, 2024
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in PTSD Checklist (PCL-5)
PTSD Symptoms. The range of the scale is from 0 (no symptoms) to 80 (maximal symptoms). Higher scores corresponds to more symptoms.
Change from baseline to 12 weeks
Social Adjustment Scale-Self Report (SAS-SR)
Functional Status. Scored 1-5, with higher scores indicating worse functioning.
Change from baseline to 12 weeks
Secondary Outcomes (1)
Veterans RAND 12 Item Health Survey Mental Component Summary (VR-12 MCS)
Change from baseline to 12 weeks
Study Arms (1)
PTSD
Veterans diagnosed with Diagnostic and Statistical Manual (DSM-V) PTSD
Interventions
Cognitive Processing Therapy is an evidence-based psychotherapy for PTSD.
Eligibility Criteria
Veterans
You may qualify if:
- DSM-5 criteria for PTSD via the Clinician Administered PTSD Scale (CAPS-5)
- Willing to initiate CPT
You may not qualify if:
- Substance use disorder (moderate or above) not in remission for \>1 mo
- Severe psychiatric illness (e.g., psychosis)
- Significant current suicidal or homicidal intent, including a specific plan
- Dementia, neurological disorder, or severe traumatic brain injury (TBI; i.e., loss of consciousness \> 24h)
- Inability to speak or read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104-4551, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. James Cobb Scott
- Organization
- Corporal Michael J. Crescenz VAMC
Study Officials
- PRINCIPAL INVESTIGATOR
James C. Scott, PhD
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2018
First Posted
August 22, 2018
Study Start
May 20, 2019
Primary Completion
September 29, 2023
Study Completion
September 29, 2023
Last Updated
May 9, 2025
Results First Posted
May 9, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- Datasets meeting VA standards for disclosure to the public will be made available within one year of publication of primary results.
Final datasets will be shared upon written request. The PI and his team will create de-identified, study-specific dataset, replacing identifying information with study-specific codes. Investigators requesting access to a dataset will be asked to sign a Letter of Agreement or Data Use Agreement that will need to be approved by the local VA Information Security Officers and Privacy Officer. The investigators will follow specific VA Office of Research \& Development Guidance.